SCHEMBL5865356

SCHEMBL5865356

O=C(O)c1cccc(/C=C/c2cccc(Cl)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.51
CYP2C9 P11712 2/20 0.51
MAOB P27338 3/20 0.49
TERT O14746 1/20 0.46
KDM4E B2RXH2 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
ACMSD Q8TDX5 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
GRM4 Q14833 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
CYSLTR2 Q9NS75 3/20 0.43
CYSLTR1 Q9Y271 3/20 0.43
CYP2D6 P10635 2/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865124 1.00 CYP1A2 (0.51) CYP1A2CYP2C9MAOBTERTKDM4E
SCHEMBL5865056 0.85 KDM4E (0.48) CYP1A2CYP2C9MAOBTERTKDM4E
SCHEMBL5865243 0.85 KDM4E (0.48) CYP1A2CYP2C9MAOBTERTKDM4E
SCHEMBL2597811 0.84 GRM4 (0.61) CYP1A2CYP2C9KDM4EALOX15TSHR
SCHEMBL2597810 0.84 GRM4 (0.61) CYP1A2CYP2C9KDM4EALOX15TSHR
SCHEMBL5865509 0.84 TERT (0.47) CYP1A2TERTKDM4EALOX15TSHR
SCHEMBL5865333 0.84 TERT (0.47) CYP1A2TERTKDM4EALOX15TSHR
SCHEMBL5865030 0.82 NFE2L2 (0.53) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL5865025 0.82 NFE2L2 (0.53) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL5864893 0.79 P4HB (0.48) MAOBMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP1A2 858/4885CYP2C9 1207/4885MAOB 249/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C CYP1A2 1135/4885CYP2C9 1512/4885MAOB 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.